Physician

Johnathan David Warminski, MD

According to 2025 Medicare claims, Johnathan Warminski, MD (NPI: 1760618250) practices ophthalmology in the Fort Worth-Arlington-Grapevine, TX market, with the plurality of this provider's patient population coming from Tarrant, TX. This provider's primary affiliated billing organization is JAWAD A QURESHI MD PA (NPI: 1881994713; TIN: 27-3557509) and primary practice location at 76107-5747.

Warminski's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,777 traditional Medicare patients, billed 120,706 HCPCS/CPT codes, and received $5,248,040 in Medicare payments. The top billing code was 92004 (New patient complete exam of visual system). Part D data shows 582 prescription claims across 268 beneficiaries totaling $35,080 in drug costs, led by Tobramycin-Dexamethasone (Tobramycin/Dexamethasone). Open Payments data shows 76 records totaling $1,864. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $220,011 to $5,248,040. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $18,763 to $35,080. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$2.6M$5.2M2015 Medicare payment: $220,011 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $383,549 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $688,144 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $829,170 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,186,416 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,423,855 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,786,951 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,268,370 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $3,614,365 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $5,248,040 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20152642,162$220,011
20164544,245$383,549
20177397,001$688,144
20188807,767$829,170
20191,1179,658$1,186,416
20201,19310,578$1,423,855
20211,27811,947$1,786,951
20221,43216,090$2,268,370
20231,50766,394$3,614,365
20241,777120,706$5,248,040

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$35K$71K2015 Drug cost: $18,763 (USD; Tot_Drug_Cst)2016 Drug cost: $23,873 (USD; Tot_Drug_Cst)2017 Drug cost: $16,912 (USD; Tot_Drug_Cst)2018 Drug cost: $29,870 (USD; Tot_Drug_Cst)2019 Drug cost: $36,392 (USD; Tot_Drug_Cst)2020 Drug cost: $44,918 (USD; Tot_Drug_Cst)2021 Drug cost: $51,432 (USD; Tot_Drug_Cst)2022 Drug cost: $70,907 (USD; Tot_Drug_Cst)2023 Drug cost: $62,134 (USD; Tot_Drug_Cst)2024 Drug cost: $35,080 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015103292$18,763
2016112301$23,873
2017125335$16,912
2018162448$29,870
2019202563$36,392
2020194611$44,918
2021193631$51,432
2022258777$70,907
2023232656$62,134
2024268582$35,080

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
92004New patient complete exam of visual system364364$109
67028Injection of drug into eye5142,527$103
92014Established patient complete exam of visual system1,4924,044$97
92134Imaging of retina1,6634,385$32
J2777Injection, faricimab-svoa, 0.1 mg29295,474$27

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Tobramycin-DexamethasoneTobramycin/Dexamethasone1153,148$8,785
Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol281,827$4,771
Prednisolone AcetatePrednisolone Acetate773,243$3,904
CombiganBrimonidine Tartrate/Timolol12516$3,823
Brimonidine TartrateBrimonidine Tartrate231,072$1,239

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.76$1,864Regeneron Healthcare Solutions, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Johnathan David Warminski, MD?

Tedicare shows public-source Medicare data for Johnathan David Warminski, MD (NPI 1760618250), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Johnathan David Warminski, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Johnathan David Warminski, MD?

Johnathan David Warminski, MD is linked to JAWAD A QURESHI MD PA (billing NPI 1881994713) in the available physician profile data.

Does Johnathan David Warminski, MD have Open Payments data?

Johnathan David Warminski, MD has 76 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.